MedPath

K-104-CR Phase II Exploratory study

Phase 2
Conditions
Hypercholesterolemia
Registration Number
JPRN-jRCT2080222137
Lead Sponsor
Kowa Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
24
Inclusion Criteria

Patients with hypercholesterolemia

Exclusion Criteria

Those complicated with Type 1 diabetes mellitus or poorly controlled Type 2 diabetes mellitus
Those complicated with poorly controlled hypertension
Those complicated with poorly controlled thyroid disorder
Those complicated with renal disorder
Those complicated with muscular disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DL-C percent change at 6th week of treatment<br>Central laboratory test
Secondary Outcome Measures
NameTimeMethod
Percent changes of lipid parameters at 2nd, 4th or 6th week of treatment<br>Central laboratory test
© Copyright 2025. All Rights Reserved by MedPath